In the Spring 2021 edition of this newsletter Dr Rakesh Popat, Consultant Haematologist and Cancer Lead at the CRF, discusses running an early phase cancer trials programme during a pandemic.
Prof Daniel Hochhauser, Co-Director of the BRC’s Cancer Theme, writes about the importance of early phase clinical trials in cancer and how the CRF’s work links to the work of the BRC.
And study participants give their perspective on why patient and public involvement in research is so important.
